📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platform. (2018)

First Author: Gilbert DC

Attributed to: CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bju.14153

PubMed Identifier: 29388336

Publication URI: http://europepmc.org/abstract/MED/29388336

Type: Journal Article/Review

Volume: 121

Parent Publication: BJU international

Issue: 5

ISSN: 1464-4096